Miji International Holdings Limited (1715) AI Stock Analysis

• Market Cap: HK$187.60M
• Dividend Yield: N/A
• Average Volume (3M): 1.96M
• Price to Earnings (P/E): ―
• Beta (1Y): -0.18
• Revenue Growth: -32.54%
• EPS Growth: 71.35%
• Country: HK
• Employees: 69
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Furnishings, Fixtures & Appliances
• EPS (TTM): -0.09
• Shares Outstanding: 360,759,900
• 10 Day Avg. Volume: 531,640
• 30 Day Avg. Volume: 1,958,200
• PEG Ratio: 0.01
• Price to Book (P/B): 0.53
• Price to Sales (P/S): 0.24
• P/FCF Ratio: -0.62
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 44 Neutral
• Price Target: HK$0.50 ▲(56.25% Upside)

The overall stock score of 44 reflects significant financial challenges, including declining revenues and persistent losses. While technical indicators show some potential for upward momentum, the negative P/E ratio and lack of dividend yield highlight valuation concerns. The absence of earnings call data and corporate events limits additional insights.

Miji International Holdings Limited Business Overview & Revenue Model

Company Description

Miji International Holdings Limited (1715) is a Hong Kong-based investment holding company primarily engaged in the manufacturing and sale of a diverse range of consumer products. The company operates across several sectors, including homeware, electronics, and personal care, providing innovative and quality products to customers. Miji International focuses on leveraging its strong supply chain and design capabilities to deliver value-added products while maintaining competitive pricing in the market.

How the Company Makes Money

Miji International Holdings Limited generates revenue primarily through the sale of its consumer products, which are distributed both domestically and internationally. The company operates a multi-channel revenue model, which includes direct sales through retail partnerships, online platforms, and export sales to overseas markets. Key revenue streams include the sale of homeware products, electronics, and personal care items. Additionally, Miji International benefits from strategic partnerships with retailers and distributors, enhancing its market reach and enabling bulk sales. The company's focus on product innovation and quality helps to attract a loyal customer base, further contributing to its revenue growth.

Miji International Holdings Limited Financial Statement Overview

Summary

Miji International Holdings Limited is facing significant financial challenges, with declining revenues, persistent losses, and increasing leverage. The company's financial health is under pressure, with negative cash flows and deteriorating balance sheet metrics. These factors suggest a need for strategic restructuring to improve financial stability and performance.

Income Statement

The company has been experiencing declining revenue over the past few years, with a significant decrease from 2019 to 2024. Gross profit margins have also deteriorated, indicating challenges in maintaining profitability. The company has consistently reported negative EBIT and net income, reflecting ongoing operational losses and financial difficulties.

Balance Sheet

The balance sheet shows a concerning trend with decreasing stockholders' equity and increasing debt levels. The debt-to-equity ratio has worsened, indicating higher financial leverage and potential risk. The equity ratio has also declined, suggesting reduced financial stability. These factors highlight the company's increasing reliance on debt financing.

Cash Flow

The cash flow statement reveals negative operating cash flows in recent years, signaling cash flow challenges. The free cash flow has been negative, indicating insufficient cash generation to cover capital expenditures. The operating cash flow to net income ratio is unfavorable, reflecting inefficiencies in converting income into cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	59.88M	91.89M	84.37M	88.19M	143.87M	189.38M
Gross Profit	2.59M	6.49M	21.22M	38.49M	65.27M	94.99M
EBITDA	-17.33M	-28.31M	-36.05M	-30.94M	-35.40M	-21.93M
Net Income	-24.20M	-35.85M	-49.32M	-43.21M	-44.35M	-21.13M
Balance Sheet
Total Assets	173.84M	137.47M	165.74M	193.80M	190.72M	246.34M
Cash, Cash Equivalents and Short-Term Investments	45.94M	2.30M	33.95M	11.36M	32.35M	48.18M
Total Debt	50.86M	60.74M	71.40M	79.92M	32.92M	36.65M
Total Liabilities	85.91M	95.08M	107.53M	113.90M	66.58M	73.39M
Stockholders Equity	86.62M	42.06M	58.21M	80.36M	124.27M	168.75M
Cash Flow
Free Cash Flow	-3.68M	-35.37M	13.80M	-76.70M	-13.24M	-23.02M
Operating Cash Flow	-3.61M	-35.21M	14.42M	-75.93M	-11.02M	-19.19M
Investing Cash Flow	-18.00K	-101.00K	-2.00K	15.03M	6.67M	-8.57M
Financing Cash Flow	3.07M	3.63M	8.13M	39.30M	-10.74M	-9.10M

Miji International Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.32
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1715, the sentiment is Positive. The current price of 0.32 is below the 20-day moving average (MA) of 0.55, below the 50-day MA of 0.42, and above the 200-day MA of 0.31, indicating a neutral trend. The MACD of 0.03 indicates Positive momentum. The RSI at 53.95 is Neutral, neither overbought nor oversold. The STOCH value of 12.12 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1715.

Miji International Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2381	72 Outperform	HK$262.00M	10.00	18.10%	7.25%	10.65%	25.96%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
0396	53 Neutral	HK$92.12M	5.45	20.69%	8.77%	-13.44%	―
6822	51 Neutral	HK$287.00M	-12.73	-4.25%	9.64%	8.85%	-18.82%
1715	44 Neutral	HK$187.60M	―	-39.50%	―	-32.54%	71.35%
0684	44 Neutral	HK$183.18M	―	-12.11%	27.27%	-4.04%	-39.02%
2127	41 Neutral	HK$76.58M	―	―	―	-72.73%	-764.81%

Miji International Holdings Limited Corporate Events

AI Health Technology Updates Capital Reorganization Timeline

AI Health Technology Limited has announced an update on its proposed capital reduction and share sub-division, with a revised timetable for the capital reorganization. The Grand Court of the Cayman Islands will hear the petition for confirmation of the capital reduction on 26 November 2025, and the expected effective date for the capital reorganization is set for 1 December 2025. This move is anticipated to streamline the company’s capital structure and potentially enhance its market positioning.

The most recent analyst rating on (HK:1715) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Miji International Holdings Limited stock, see the HK:1715 Stock Forecast page.

AI Health Technology Limited Grants 6 Million Share Options to Employees

AI Health Technology Limited announced the grant of 6,000,000 share options to eight employees, including one senior management member, under its Share Option Scheme. This initiative aims to recognize and motivate employees’ contributions to the company, aligning with the company’s strategy to retain talent and optimize performance without imposing additional performance targets.

The most recent analyst rating on (HK:1715) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Miji International Holdings Limited stock, see the HK:1715 Stock Forecast page.

AI Health Technology Limited Expands in Healthcare with New Strategic Initiatives

AI Health Technology Limited has announced strategic initiatives to expand its presence in the healthcare industry, focusing on artificial general intelligence and digitalization to create an intelligent health management platform. The company has established a subsidiary and formed a research team to develop a platform for real-time health data monitoring, which is expected to significantly increase revenue. Additionally, the company is expanding into the high-end healthcare sector through strategic partnerships and joint ventures, aiming to generate positive cash flow by 2026. The company is also strengthening its trade in health and personal care products by enhancing its e-commerce channels and supply chain layout to capture the growing market for elderly-friendly products.

The most recent analyst rating on (HK:1715) stock is a Sell with a HK$0.50 price target. To see the full list of analyst forecasts on Miji International Holdings Limited stock, see the HK:1715 Stock Forecast page.

AI Health Technology Limited Approves Capital Restructuring at EGM

AI Health Technology Limited announced that all proposed resolutions were passed at their Extraordinary General Meeting held on September 3, 2025. This includes the approval of a Capital Reduction and Share Sub-division, which received unanimous support from shareholders. The company is now proceeding with the necessary legal steps to finalize these changes, which are expected to impact the company’s capital structure and shareholder value.

The most recent analyst rating on (HK:1715) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Miji International Holdings Limited stock, see the HK:1715 Stock Forecast page.

AI Health Technology Limited Reports Interim Results with Declining Revenue

AI Health Technology Limited reported its interim results for the six months ended June 30, 2025, revealing a significant decline in revenue and gross profit compared to the previous year. Despite a reduction in net loss, the company continues to face financial challenges, impacting its operations and market positioning.

The most recent analyst rating on (HK:1715) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Miji International Holdings Limited stock, see the HK:1715 Stock Forecast page.

AI Health Technology Limited Announces Capital Reorganization Plan

AI Health Technology Limited has announced an extraordinary general meeting to discuss a special resolution involving a capital reorganization. The proposal includes reducing the nominal value of each issued share and subdividing authorized but unissued shares, which aims to enhance the company’s financial flexibility by transferring the credit from the capital reduction to the distributable reserve account. This move is expected to position the company more favorably in the market by potentially offsetting accumulated losses and optimizing capital structure.